Open an account

United-Guardian

UG · NASDAQ

$6.76−$0.0497 (−0.73%)TodayMarket closed ·
Prev close $6.81

About UG

United-Guardian, Inc. engages in the development and manufacture of pharmaceuticals, cosmetic ingredients, personal and health care products and medical devices. The company is headquartered in Hauppauge, New York and currently employs 23 full-time employees. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.

Employees
23
Headquarters
Hauppauge, New York
Listed
Mar 17, 1980
Sector
Consumer Staples
Industry
Personal Care Products
Website
u-g.com

UG key statistics

Market cap
31.06M
Price-earnings ratio
12.61
Dividend yield
7.57%
Average volume
11.48K
Volume
6.47K
Open price
$6.81
High today
$6.91
Low today
$6.61
52 Week high
$8.45
52 Week low
$5.58

United-Guardian (UG) at a glance

As of Oct 20, 2026, United-Guardian (UG) shares are priced at $6.76, giving the company a market cap of 31.06M, a price-to-earnings ratio of 12.61 and a dividend yield of 7.57%.

Today the stock has traded between $6.61 and $6.91. The current price is 2.3% above the day's low and 2.2% below its high.

Volume so far is 6.47K shares, below the average of 11.48K shares a day.

Over the past year United-Guardian has ranged from $5.58 to $8.45, and now sits 41% of the way up that range.

United-Guardian met or beat analyst EPS estimates in 5 of the last 5 quarters. In Q2 FY26 it reported $0.16 per share against an estimate of $0.00.

UG earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 5 quarters, by 0.0% on average.

  1. Q2 FY23: reported $0.10 per share against an estimate of $0.00
  2. Q2 FY24: reported $0.21 per share against an estimate of $0.00
  3. Q1 FY25: reported $0.12 per share against an estimate of $0.00
  4. Q2 FY25: reported $0.14 per share against an estimate of $0.00
  5. Q2 FY26: reported $0.16 per share against an estimate of $0.00

UG news

  • Avi Kapoor

    Top 3 Defensive Stocks You'll Regret Missing This Month

Similar companies

Companies in the same industry as United-Guardian

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.